GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Neuland Laboratories Ltd

Neuland Laboratories: Final Dividend Record Date Fixed as July 24, 2026

DIVIDEND ▲ Positive Development LOW RISK
📅 Filed on BSE: 12 May 2026, 05:50 PM IST  ·  BSE ID: 8e4821a4-1942-4d5e-bde2-07c44fc5cd8e
View Original BSE Filing (PDF)
💡
In Simple Terms
Neuland Laboratories set July 24, 2026, as the deadline for shareholders to be eligible for the Rs. 3.4 per share dividend.
🤖 AI Summary
  • Neuland Laboratories fixed July 24, 2026, as the record date for the final dividend for FY26.
  • The board previously recommended a final dividend of Rs. 3.4 per equity share for FY26.
  • Audited financial results (standalone & consolidated) for the year ended March 31, 2026, were approved.
  • Dr. Maturi Fucitora (DIN 11699767A) was appointed as a Non-Executive Non-Independent Additional Director.
  • Capacity expansion of 120.5 KL at Unit 1, with an investment of Rs. 143.4 crore, was approved.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Final Dividend per Equity Share
Rs. 3.4
Proposed Additional Capacity
120.5 KL
Investment for Capacity Expansion
Rs. 143.4 crore
Existing Capacity (Unit 1)
256 KL
Existing Capacity Utilization (Unit 1)
91%
🏢 How This Affects the Company
📈
Business Impact
The approved capacity expansion of 120.5 KL aims to address growing customer demand, supporting potential future revenue growth.
💰
Financial Impact
The Rs. 143.4 crore investment for capacity expansion will be financed through internal accruals and borrowings, impacting cash flow and potentially debt levels over 12-18 months.
⚙️
Operational Impact
Operational capacity will increase by 120.5 KL at Unit 1, taking 12 to 18 months to add, enhancing production capabilities.
👥 What This Means For Shareholders
✅
Action Required
Shareholders must ensure their shares are held in dematerialized form by July 24, 2026, to be eligible for the final dividend.
👤
Who Is Affected
Shareholders holding Neuland Laboratories equity shares as of the record date, July 24, 2026, will be eligible to receive the Rs. 3.4 per equity share final dividend.
🔍
Management Signal
Management intends to return capital to shareholders via dividends while simultaneously investing in capacity expansion to support future business growth.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Dividend payment date — verify the payment of the declared dividend post-AGM.
Q1 FY27 results — monitor financial performance following dividend and expansion plans.
Updates on capacity expansion — track progress on the 12-18 month project timeline.
LOW RISK The filing primarily details a dividend record date and an approved capacity expansion with defined funding.
💡 Investor Takeaway
Neuland Laboratories has set July 24, 2026, as the record date for the Rs. 3.4 per equity share final dividend for FY26. The company also approved a Rs. 143.4 crore capacity expansion of 120.5 KL at Unit 1, to be completed in 12-18 months.
⚖️ Strengths & Concerns

✅ Positives

  • Approval of a final dividend of Rs. 3.4 per equity share for FY26 provides direct returns to shareholders.
  • Capacity expansion of 120.5 KL at Unit 1 aims to meet growing customer demand and maintain competitiveness.

⚠️ Concerns

  • The Rs. 143.4 crore investment for capacity expansion over 12-18 months represents a significant capital outlay.
  • Financing the capacity expansion through borrowings will increase the company's debt obligations.
📅 Company Track Record
A past filing on May 12, 2026, indicated Neuland Labs' recommendation of a Rs. 3.4 final dividend and plans for a Rs. 143.4 crore capacity expansion. This current filing confirms the record date for the previously announced dividend.

Based on publicly available historical data. For context only.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.